Safe and Effective Administration of Caplacizumab in COVID-19-Associated Thrombotic Thrombocytopenic Purpura

Thrombotic thrombocytopenic purpura (TTP) is a potentially life-threatening, rare acute thrombotic microangiopathy (TMA), caused by a severe ADAMTS13 deficiency. As the COVID-19 pandemic rapidly spread around the globe, much data about the pathogenicity of this virus were published. Soon after the d...

وصف كامل

التفاصيل البيبلوغرافية

المؤلفون الرئيسيون:	Antonella Bruzzese, Ernesto Vigna, Dario Terzi, Sonia Greco, Enrica Antonia Martino, Valeria Vangeli, Francesco Mendicino, Eugenio Lucia, Virginia Olivito, Caterina Labanca, Rosellina Morelli, Antonino Neri, Fortunato Morabito, Francesco Zinno, Antonio Mastroianni, Massimo Gentile
التنسيق:	Artigo
اللغة:	Inglês
منشور في:	MDPI AG 2023-07-01
سلاسل:	Hematology Reports
الموضوعات:	COVID-19 TTP caplacizumab
الوصول للمادة أونلاين:	https://www.mdpi.com/2038-8330/15/3/46
الوسوم:	إضافة وسم لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!